Showing results (151-160 of 236) with videos related to
Sort By:
Pageof 24
International Journal of Molecular Sciences|August 28, 2025
AI-Based Facial Phenotyping Supports a Shared Molecular Axis in <i>PACS1</i>-, <i>PACS2</i>-, and <i>WDR37</i>-Related SyndromesJulia Del Rincón, Marta Gil-Salvador, Cristina Lucia-Campos, et al.Experimental Dermatology|January 29, 2024
Association between several immune response-related genes and the effectiveness of biological treatments in patients with moderate-to-severe psoriasisAlba Loras, Marta Gil-Barrachina, Barbara Hernando, et al.Frontiers in Pharmacology|October 26, 2018
Finerenone Attenuates Endothelial Dysfunction and Albuminuria in a Chronic Kidney Disease Model by a Reduction in Oxidative StressRaquel González-Blázquez, Beatriz Somoza, Marta Gil-Ortega, et al.Cureus|May 2, 2024
Assessment of Quality of Life Using the Kidslife Scale in Individuals With Cornelia de Lange SyndromeLaura Trujillano, Ariadna Ayerza-Casas, Beatriz Puisac, et al.Frontiers in Endocrinology|December 4, 2013
Remodeling of energy metabolism and absence of electrophysiological changes in the heart of obese hyperleptinemic mice. New insights into the pleiotropic role of leptinRocío Guzmán-Ruiz, Nieves Gómez-Hurtado, Marta Gil-Ortega, et al.International Journal of Molecular Sciences|May 28, 2022
The Aryl Hydrocarbon Receptor Ligand FICZ Improves Left Ventricular Remodeling and Cardiac Function at the Onset of Pressure Overload-Induced Heart Failure in MiceMaría Tamayo, Laura Martín-Nunes, María José Piedras, et al.Scientific Reports|March 11, 2022
Novel indolic AMPK modulators induce vasodilatation through activation of the AMPK-eNOS-NO pathwayMarta Sanz-Gómez, Elnaz Aledavood, Marina Beroiz-Salaverri, et al.Cell Reports|April 11, 2019
The Release of Adipose Stromal Cells from Subcutaneous Adipose Tissue Regulates Ectopic Intramuscular Adipocyte DepositionAmandine Girousse, Marta Gil-Ortega, Virginie Bourlier, et al.Oncotarget|October 27, 2017
A phase I study of the SRC kinase inhibitor dasatinib with trastuzumab and paclitaxel as first line therapy for patients with HER2-overexpressing advanced breast cancer. GEICAM/2010-04 studyAlberto Ocana, Marta Gil-Martin, Miguel Martín, et al.Scientific Reports|July 1, 2025
Postzygotic mosaicism in SMC1A and the first reported case of a female with Cornelia de Lange syndromeMarta Gil-Salvador, Laura Trujillano, Cristina Lucia-Campos, et al.Pageof 24